Pioglitazone
- Product NDC
- 68071-2886
- 11-digit product format
- 680712886
- Labeler code
- 68071
- Product ID
- 68071-2886_ee00c2b1-e744-2e85-e053-2995a90aa68c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA200268
- Marketing category
- ANDA
- Marketing start
- 2013-02-13
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68071-2886 | I | Inactivated by FDA | 2026-08-07 | ||
| excluded package | package | 68071-2886 | 68071-2886-3 | I | Inactivated by FDA | 2026-08-07 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 68071-2886-3 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68071-2886-3 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68071-2886-3 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68071-2886-3 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68071-2886-3 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68071-2886-3 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-2886-3 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-2886-3 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-2886-3 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200268-001 | PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | |
| A200268-002 | PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | |
| A200268-003 | PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A200268-001 | AB |
| A200268-002 | AB |
| A200268-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200268-002 | PIOGLITAZONE HYDROCHLORIDE | EQ 30MG BASE | TABLET / ORAL | AB | 2013-02-13 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200268-003 | PIOGLITAZONE HYDROCHLORIDE | EQ 45MG BASE | TABLET / ORAL | AB | 2013-02-13 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A200268-001 | PIOGLITAZONE HYDROCHLORIDE | EQ 15MG BASE | TABLET / ORAL | AB | 2013-02-13 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A200268-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200268-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200268-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200268-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200268-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200268-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A200268-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200268-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200268-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200268-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200268-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200268-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200268-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200268-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200268-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200268-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200268-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200268-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200268-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200268-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200268-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200268-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200268-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200268-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200268-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200268-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A200268-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A200268-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A200268-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A200268-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200268-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200268-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A200268-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200268-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200268-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A200268-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200268-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200268-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A200268-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A200268-001 | AB | 1 | 8072bd15b7f6… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e11f0f31-8914-938f-521e-037b6de27c13 | Product name | 5 | 20210621 |
| 3e9b6ece-066b-2ac3-28f7-5e13060e5934 | Product name | 2 | 20151109 |
| 0d79b284-47e8-e90c-f249-892b9b251003 | Product name | 1 | 20140508 |
| 7611093e-8875-33d4-9e3c-f48c7e3af1e8 | Product name | 1 | 20140508 |
| ac29cd77-922c-d25a-f8ad-66a8692935c5 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-2886-3 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-af2c-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use PIOGLITAZONE TABLETS safely and effectively. See full prescribing information for PIOGLITAZONE TABLETS. PIOGLITAZONE tablets, for oral use Initial U.S. Approval: 1999 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2886-3 | Pioglitazone | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2886 | PIOGLITAZONE TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Legacy NDC, 1 package rows | 20221124_ee00c2b1-e777-2e85-e053-2995a90aa68c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pioglitazone | PIOGLITAZONE | Major Pharmaceuticals | 72b46a1e-d9ea-4a47-95ef-5eae96ef1e7f | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 6cd7c8b7-f5d4-423b-ae9f-86541869d8cf | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | Bryant Ranch Prepack | 466ef4c8-84d4-4ded-8505-a33f12adf31c | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | e64b46e5-3c94-4635-908e-cdc2263bd3d4 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | REMEDYREPACK INC. | 3a9f6777-9b4f-482a-aa4e-4900f9d35b8e | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | REMEDYREPACK INC. | 55f9b2d8-3e78-4e2f-bcf1-d00595078fa1 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 41a9586c-8768-4fc3-bb78-e6d98b09030b | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 29073b0a-1d7e-4354-87c7-e764106978d8 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | REMEDYREPACK INC. | 04577c39-a9c0-4c66-a775-4c79e2c3dea5 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | Preferred Pharmaceuticals, Inc. | 164c444c-7c56-4482-9cbd-0e0f0ad30c44 | 2025-09-09 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | Preferred Pharmaceuticals, Inc. | 060e3169-46a7-419d-9acc-05586cb2406b | 2025-09-09 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | Bryant Ranch Prepack | c9548800-4c44-473d-a89b-c705484548b3 | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | Bryant Ranch Prepack | 6397fb4c-081b-4abd-ab4b-0a3fbf99e663 | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | Aurobindo Pharma Limited | 1f259863-21fd-4d62-b094-4eff845944df | 2025-05-17 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | QUALLENT PHARMACEUTICALS HEALTH LLC | 0331400c-b163-4856-bfb0-965470247cb3 | 2025-05-17 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | Rising Pharma Holdings, Inc. | 4483b1c6-7095-4a63-8128-ac2d91e11040 | 2025-05-17 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| PIOGLITAZONE | PIOGLITAZONE | DIRECT RX | a7e8d5a3-b0da-1d70-e053-2a95a90aa435 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | Bryant Ranch Prepack | f6cad01e-cd65-4c8d-9e49-399404f22005 | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | a1112e4b-e9d5-13c3-e053-2995a90a6d0a | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | a0846e3e-68b2-fd55-e053-2995a90a673e | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 200268 ANDA200268 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 317573 | pioglitazone 15 MG Oral Tablet | PSN | ee00c2b1-e777-2e85-e053-2995a90aa68c | 1 |
| 317573 | pioglitazone 15 MG Oral Tablet | SCD | ee00c2b1-e777-2e85-e053-2995a90aa68c | 1 |
| 317573 | pioglitazone (as pioglitazone hydrochloride) 15 MG Oral Tablet | SY | ee00c2b1-e777-2e85-e053-2995a90aa68c | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-2886-3 | 68071288603 | 30 TABLET in 1 BOTTLE (68071-2886-3) | 30 tablet | 2022-11-21 | 0000-00-00 | No | No | Current |